Melatonin: an Inhibitor of Breast Cancer

समान संसाधन

• Doxorubicin Resistance in Breast Cancer is Driven by Light at Night Induced Disruption of the Circadian Melatonin Signal
  द्वारा: Xiang, Shulin, और अन्य
  प्रकाशित: (2015)
• Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer
  द्वारा: Dauchy, Robert T., और अन्य
  प्रकाशित: (2014)
• Molecular deficiency (ies) in MT(1) melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells
  द्वारा: Mao, Lulu, और अन्य
  प्रकाशित: (2014)
• Melatonin Represses Metastasis in Her2-postive Human Breast Cancer Cells by Suppressing RSK2 Expression
  द्वारा: Mao, Lulu, और अन्य
  प्रकाशित: (2016)
• Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer
  द्वारा: Xiang, Shulin, और अन्य
  प्रकाशित: (2019)